Form 4: Select Medical Holdings Director Katherine R. Davisson Reports Stock Grant and Disposal

Director Katherine R. Davisson reported receiving a grant of 10,000 shares of Select Medical Holdings Corp. common stock and disposing of 46,000 shares on April 30, 2024.

Summary

• Katherine R. Davisson, a director of Select Medical Holdings Corp., filed a Form 4 with the SEC.
• The report details a transaction on April 30, 2024, where Ms. Davisson acquired 10,000 shares of common stock through a grant.
• The grant was priced at $0.
• These shares vest on April 30, 2025.
• Ms. Davisson also disposed of 46,000 shares of common stock.
• Following the reported transactions, Ms. Davisson beneficially owns 46,000 shares of Select Medical Holdings Corp.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing. The stock disposal could raise concerns, but without further context, it's difficult to assess the overall impact.

Positives

• The grant of restricted stock to a director could be seen as an incentive to align their interests with the company's long-term performance.

Negatives

• The disposal of 46,000 shares by a director could be interpreted negatively by investors, although the reason for the disposal is not disclosed.

Risks

• The Form 4 filing itself doesn't inherently present risks, but the market's reaction to the director's stock disposal could introduce short-term price volatility.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gain insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may react to the director's stock disposal, potentially influencing the stock price.

Key Dates